Acute coronary syndrome: how to reduce the residual inflammatory risk?
Inflammatory mediators play an important role in the pathogenesis of acute coronary syndrome (ACS). The results of experimental and randomized clinical trials on the role of various inflammation inhibitors in the treatment of coronary artery disease (CAD), in particular CANTOS and COLCOT, mark a new...
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Russo |
| Хэвлэсэн: |
«FIRMA «SILICEA» LLC
2020-03-01
|
| Цуврал: | Российский кардиологический журнал |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://russjcardiol.elpub.ru/jour/article/view/3720 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|